Q5125 Injection, releuko 1 micrograms
Also known as: Releuko injection, filgrastim-ayow, G-CSF
Injection of Releuko, filgrastim-ayow biosimilar per 1 microgram, a granulocyte-colony stimulating factor.
In Plain Language
white blood cell booster; infection prevention injection
Clinical Context
Used for chemotherapy-related neutropenia and patients with congenital neutropenia disorders.
RVU Information
CPT Q5125 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5125?
CPT Q5125 (Injection, releuko 1 micrograms) is a Q Codes code. Injection of Releuko, filgrastim-ayow biosimilar per 1 microgram, a granulocyte-colony stimulating factor.
Is Q5125 covered by insurance?
Q5125 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for chemotherapy-related neutropenia and patients with congenital neutropenia disorders.
When is CPT Q5125 used?
Used for chemotherapy-related neutropenia and patients with congenital neutropenia disorders.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.